These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3005568)

  • 1. Antiarrhythmic activity of 17 beta-aminoestratrienes. Comparison of 3-ols and 3-acetates with the corresponding 3-(3-amino-2-hydroxypropyl) ethers.
    Campbell JK; Logan RT; Marshall RJ; McGarry G; Sleigh T; Winslow E
    J Med Chem; 1986 Feb; 29(2):244-50. PubMed ID: 3005568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological studies on propafenone and its main metabolite 5-hydroxypropafenone.
    von Philipsborn G; Gries J; Hofmann HP; Kreiskott H; Kretzschmar R; Müller CD; Raschack M; Teschendorf HJ
    Arzneimittelforschung; 1984; 34(11):1489-97. PubMed ID: 6543124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological and antiarrhythmic properties of propafenon in isolated cardiac preparations.
    Ledda F; Mantelli L; Manzini S; Amerini S; Mugelli A
    J Cardiovasc Pharmacol; 1981; 3(6):1162-73. PubMed ID: 6173515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological effects of propafenone in untreated and propafenone-pretreated guinea-pig atrial and ventricular muscle fibres.
    Delgado C; Tamargo J; Tejerina T
    Br J Pharmacol; 1985 Dec; 86(4):765-75. PubMed ID: 4075015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of beta adrenoceptor blockade by propafenone hydrochloride: clinical pharmacologic, radioligand binding and adenylate cyclase activation studies.
    McLeod AA; Stiles GL; Shand DG
    J Pharmacol Exp Ther; 1984 Feb; 228(2):461-6. PubMed ID: 6141285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenoceptor blocking activity of diprafenone in anesthetized dogs: comparison with propafenone and propranolol.
    Greenberg S; Cantor E; Paul J
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):444-53. PubMed ID: 2476625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative antiarrhythmic and electrophysiological effects of drugs known to inhibit calmodulin (TFP, W7 and bepridil).
    Barron E; Marshall RJ; Martorana M; Winslow E
    Br J Pharmacol; 1986 Nov; 89(3):603-12. PubMed ID: 3492234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BW A256C, a chemically novel class 1 antiarrhythmic agent. A comparison of in vitro and in vivo activity with other class 1 antiarrhythmic agents.
    Allan G; Donoghue S; Follenfant MJ; Sawyer DA
    Br J Pharmacol; 1986 Jun; 88(2):333-43. PubMed ID: 3730698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Org 7797 on early, late and inducible arrhythmias following coronary artery occlusion in rats and dogs.
    Winslow E; Campbell JK; Barron E; Marshall RJ; Muir AW
    Br J Pharmacol; 1991 Dec; 104(4):853-8. PubMed ID: 1810599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenoceptor studies. 2. Effects of alkyl substitution on beta-adrenoceptor blocking, antiarrhythmic, and local anesthetic activities of 1,1'-(o-phenylenedioxy)bis(3-isopropylamino-2-propanol).
    Zaagsma J; Nauta WT
    J Med Chem; 1977 Apr; 20(4):527-31. PubMed ID: 15113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The multiple modes of action of propafenone.
    Dukes ID; Vaughan Williams EM
    Eur Heart J; 1984 Feb; 5(2):115-25. PubMed ID: 6144546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic effects of two new propafenone related drugs. A study on four animal models of arrhythmia.
    Wascher TC; Dittrich P; Kukovetz WR
    Arzneimittelforschung; 1991 Feb; 41(2):119-24. PubMed ID: 2043172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative chronotropic effect of a novel class III antiarrhythmic drug, UK-68,798, devoid of beta-blocking action on isolated guinea-pig atria.
    Yang T; Tande PM; Refsum H
    Br J Pharmacol; 1991 Jun; 103(2):1417-20. PubMed ID: 1679359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and cardiac electrophysiological activity of aryl-substituted derivatives of the class III antiarrhythmic agent sematilide. Potential class I/III agents.
    Phillips GB; Morgan TK; Nickisch K; Lind JM; Gomez RP; Wohl RA; Argentieri TM; Sullivan ME
    J Med Chem; 1990 Feb; 33(2):627-33. PubMed ID: 2299628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic effects of alpha-adrenoceptor antagonists in guinea pig ventricular myocardium.
    Hasegawa J; Hirai S; Saitoh M; Kotake H; Mashiba H
    J Am Coll Cardiol; 1988 Dec; 12(6):1590-8. PubMed ID: 2903873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of the stereoisomers of propafenone and diprafenone in guinea-pig heart.
    Groschner K; Lindner W; Schnedl H; Kukovetz WR
    Br J Pharmacol; 1991 Mar; 102(3):669-74. PubMed ID: 1364837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antiarrhythmic activity of new 1-[1-[2-[3-(alkylamino)-2-hydroxypropoxy]phenyl]vinyl]-1 H-imidazoles and related compounds.
    Ogata M; Matsumoto H; Takahashi K; Shimizu S; Kida S; Ueda M; Kimoto S; Haruna M
    J Med Chem; 1984 Sep; 27(9):1142-9. PubMed ID: 6147415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmaco-toxicologic evaluation of newly synthesized analogs of propafenone].
    Tumová I; Racanská E; Csöllei J; Ecker G; Otrusník R; Svec P
    Ceska Slov Farm; 1997 Jun; 46(3):133-6. PubMed ID: 9440950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic action of a new beta-adrenergic blocking agent, 6-(2-hydroxy-3-isopropylaminopropyloxy)-benzothiazole succinate (KF-577), compared with that of propranolol.
    Tatsuno H; Goto K; Shigenobu K; Kasuya Y
    Eur J Pharmacol; 1976 Nov; 40(1):145-52. PubMed ID: 11105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.